Long-term Follow-up and Quality of Life of Patients Treated With Anticancer Drugs
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorInstitut Rafael
About this trial
Currently, aspects related to the effects of anticancer treatments and the quality of life of patients and their needs are still poorly documented at the Rafael Institute. Thus this study will meet a dual objective: (1) the establishment of a registry to collect data on the safety and effectiveness of innovative and expensive anticancer drugs when administered in real life and (2) a measurement quantitative quality of life of patients treated with these drugs.
Eligibility criteria
Qualifiers
Age equal to or greater than 18 years (adult)
Patients treated with an anticancer drug included in the list of innovative/expensive therapies (protocol appendix)
Patients benefiting from non-pharmacological treatment at the Rafael Institute
Who understands the French language
Disqualifiers
< 18 years old
Patient deprived of liberty, under guardianship or unable to give consent
Trial design
Treatments tested in this trial
- questionnaires
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov